Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Ursula Elsässer-Beile"'
Autor:
Anke Augspach, Joachim H. List, Philipp Wolf, Heike Bielek, Carsten Schwan, Ursula Elsässer-Beile, Klaus Aktories, Gudula Schmidt
Publikováno v:
Toxins, Vol 5, Iss 11, Pp 2241-2257 (2013)
Prostate cancer is the most common malignancy, accounting for about 25% of all incident cases among men in industrialized countries. The human androgen-dependent prostate cancer cell line LNCaP, which is derived from a metastatic lesion of human pros
Externí odkaz:
https://doaj.org/article/8846cae2c6ba4d5898cad923216e73a0
Autor:
Chizuko Tsurumi, Norbert Esser, Elke Firat, Simone Gaedicke, Marie Follo, Martin Behe, Ursula Elsässer-Beile, Anca-Ligia Grosu, Ralph Graeser, Gabriele Niedermann
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e15605 (2010)
Cancer stem cells are thought to play a pivotal role in tumor maintenance, metastasis, tumor therapy resistance and relapse. Hence, the development of methods for non-invasive in vivo detection of cancer stem cells is of great importance.Here, we des
Externí odkaz:
https://doaj.org/article/26cc4a9242094dbb8bc6400692f18710
Autor:
Bernd J. Pichler, Stefan Wiehr, Patrick Bühler, Christian Kesenheimer, Dorothee Gierschner, Philipp Wolf, Ursula Elsässer-Beile, Anna-Maria Rolle
Publikováno v:
The Prostate. 74:743-755
BACKGROUND Radioimmunoimaging with disease-specific tracers can be advantageous compared to that with nonspecific tracers for the imaging of glucose metabolism and cell proliferation. Monoclonal antibodies (mAbs) or their fragments are excellent tool
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f980646f9f611bc1d80bed4e599c69e
https://doi.org/10.1002/pros.22794
https://doi.org/10.1002/pros.22794
Autor:
Klaus Aktories, Philipp Wolf, Gudula Schmidt, Carsten Schwan, Heike Bielek, Anke Augspach, Joachim H. List, Ursula Elsässer-Beile
Publikováno v:
Toxins; Volume 5; Issue 11; Pages: 2241-2257
Toxins
Toxins, Vol 5, Iss 11, Pp 2241-2257 (2013)
Toxins
Toxins, Vol 5, Iss 11, Pp 2241-2257 (2013)
Prostate cancer is the most common malignancy, accounting for about 25% of all incident cases among men in industrialized countries. The human androgen-dependent prostate cancer cell line LNCaP, which is derived from a metastatic lesion of human pros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb6d024e693441a98fcedeaebf4776b1
https://doi.org/10.3390/toxins5112241
https://doi.org/10.3390/toxins5112241
Autor:
Ursula Elsässer-Beile, Philipp Wolf, Dieter Herchenbach, Dorothee Gierschner, Patrick Bühler, Gina J. Fiala, Wolfgang W. A. Schamel, Volker Baum
Publikováno v:
Immunotherapy. 5:27-38
Aim: Although prostate cancer is one of the most commonly diagnosed malignancies in men, there is no effective curative therapy for the advanced disease. Therefore, the aim of the present study was to generate prostate-specific membrane antigen (PSMA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1b8f1b457f5bec9db31bf077fca496d
https://doi.org/10.2217/imt.12.136
https://doi.org/10.2217/imt.12.136
Autor:
Philipp Wolf, Ursula Elsässer-Beile
Publikováno v:
Emerging Cancer Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::226c55c4253605e2dde82211c8d4cfbf
https://doi.org/10.1002/9780470626528.ch12
https://doi.org/10.1002/9780470626528.ch12
Autor:
Philipp Wolf, Arndt Katzenwadel, Patrick Bühler, Karen Alt, Ursula Elsässer-Beile, David Wetterauer, Ulrich Wetterauer, Dorothee Gierschner
Publikováno v:
Journal of Immunotherapy. 33:262-271
The prostate-specific membrane antigen (PSMA) is abundantly expressed on prostate cancer epithelial cells and its expression correlates with tumor progression. Therefore, a specific immunotherapy against this antigen may be a novel therapeutic option
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c4195fba756ac34b9708d12e5515b79
https://doi.org/10.1097/cji.0b013e3181c5495c
https://doi.org/10.1097/cji.0b013e3181c5495c
Autor:
Karen Alt, Ulrich Wetterauer, Ursula Elsässer-Beile, Philipp Wolf, Patrick Bühler, Nikolaus Freudenberg, Wolfgang Schultze-Seemann
Publikováno v:
The Prostate. 70:562-569
BACKGROUND The prostate specific membrane antigen (PSMA) represents an attractive antigen for antibody-based diagnostic and therapeutic intervention in prostate cancer, since it is highly restricted to the prostate and overexpressed in all tumor stag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14d95b91f317de7fa6fe5c7c81cca15d
https://doi.org/10.1002/pros.21090
https://doi.org/10.1002/pros.21090
Publikováno v:
Immunotherapy. 1:471-481
Prostate cancer remains a leading cause of death for men in Western civilization. Despite the effectiveness of surgical prostatectomy, radiotherapy and hormonal therapy, a significant proportion of patients progress to advanced metastatic disease for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e012ae9e2085e466a5352b92bacccf0
https://doi.org/10.2217/imt.09.17
https://doi.org/10.2217/imt.09.17
Autor:
Philipp Wolf, Ursula Elsässer-Beile
Publikováno v:
International Journal of Medical Microbiology. 299:161-176
The pathogenic bacterium Pseudomonas aeruginosa has the ability to cause severe acute and chronic infections in humans. Pseudomonas exotoxin A (PE) is the most toxic virulence factor of this bacterium. It has ADP-ribosylation activity and decisively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d76c1c68b6b633bacde1acb5f31844b
https://doi.org/10.1016/j.ijmm.2008.08.003
https://doi.org/10.1016/j.ijmm.2008.08.003